Trends in Use of Radiation Therapy for Hodgkin Lymphoma from 2000 to 2012 on the Basis of the National Cancer Data Base

Gaurav Goyal, Peter T. Silberstein, James Olen Armitage

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background Hodgkin lymphoma (HL) has come a long way from being a disease with high mortality to being highly curable, which thereby exposes survivors to the potential for long-term toxicities. Our aim was to analyze the National Cancer Data Base for trends in radiation therapy use among all stages of HL from 2000 to 2012 and to see if increased recognition of these risks has decreased the use of radiation therapy. Patients and Methods This was a retrospective study of patients diagnosed with HL (stage I-IV) between the years 2000 and 2012 using the National Cancer Data Base (n = 24,118). The National Cancer Data Base is a nationwide oncology outcomes database for more than 1500 American College of Surgeons Commission on Cancer accredited cancer programs. The study focused on the proportion of patients who received radiation therapy. Results Between the years 2000 and 2012, use of radiation therapy declined among all stages of HL (stage I: 53% to 40%, P =.0002; stage II: 52% to 36%, P <.0001; stage III: 21% to 10%, P <.0001; stage IV: 17% to 9%; P =.0002). Conclusion There has been a significant decline in the use of radiation therapy from 2000 to 2012 among all stages of HL, perhaps because of the studies that showed an increase in late complications with use of radiation therapy.

Original languageEnglish (US)
Pages (from-to)12-17
Number of pages6
JournalClinical Lymphoma, Myeloma and Leukemia
Volume16
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Hodgkin Disease
Radiotherapy
Databases
Neoplasms
Survivors
Retrospective Studies
Mortality

Keywords

  • Adult
  • Cardiotoxicity
  • Complications
  • Radiotherapy
  • Survivors

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Trends in Use of Radiation Therapy for Hodgkin Lymphoma from 2000 to 2012 on the Basis of the National Cancer Data Base. / Goyal, Gaurav; Silberstein, Peter T.; Armitage, James Olen.

In: Clinical Lymphoma, Myeloma and Leukemia, Vol. 16, No. 1, 01.01.2016, p. 12-17.

Research output: Contribution to journalArticle

@article{c3df3f81650c4c9bbcf617b3baf87113,
title = "Trends in Use of Radiation Therapy for Hodgkin Lymphoma from 2000 to 2012 on the Basis of the National Cancer Data Base",
abstract = "Background Hodgkin lymphoma (HL) has come a long way from being a disease with high mortality to being highly curable, which thereby exposes survivors to the potential for long-term toxicities. Our aim was to analyze the National Cancer Data Base for trends in radiation therapy use among all stages of HL from 2000 to 2012 and to see if increased recognition of these risks has decreased the use of radiation therapy. Patients and Methods This was a retrospective study of patients diagnosed with HL (stage I-IV) between the years 2000 and 2012 using the National Cancer Data Base (n = 24,118). The National Cancer Data Base is a nationwide oncology outcomes database for more than 1500 American College of Surgeons Commission on Cancer accredited cancer programs. The study focused on the proportion of patients who received radiation therapy. Results Between the years 2000 and 2012, use of radiation therapy declined among all stages of HL (stage I: 53{\%} to 40{\%}, P =.0002; stage II: 52{\%} to 36{\%}, P <.0001; stage III: 21{\%} to 10{\%}, P <.0001; stage IV: 17{\%} to 9{\%}; P =.0002). Conclusion There has been a significant decline in the use of radiation therapy from 2000 to 2012 among all stages of HL, perhaps because of the studies that showed an increase in late complications with use of radiation therapy.",
keywords = "Adult, Cardiotoxicity, Complications, Radiotherapy, Survivors",
author = "Gaurav Goyal and Silberstein, {Peter T.} and Armitage, {James Olen}",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.clml.2015.11.006",
language = "English (US)",
volume = "16",
pages = "12--17",
journal = "Clinical Lymphoma, Myeloma and Leukemia",
issn = "2152-2669",
publisher = "Cancer Media Group",
number = "1",

}

TY - JOUR

T1 - Trends in Use of Radiation Therapy for Hodgkin Lymphoma from 2000 to 2012 on the Basis of the National Cancer Data Base

AU - Goyal, Gaurav

AU - Silberstein, Peter T.

AU - Armitage, James Olen

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background Hodgkin lymphoma (HL) has come a long way from being a disease with high mortality to being highly curable, which thereby exposes survivors to the potential for long-term toxicities. Our aim was to analyze the National Cancer Data Base for trends in radiation therapy use among all stages of HL from 2000 to 2012 and to see if increased recognition of these risks has decreased the use of radiation therapy. Patients and Methods This was a retrospective study of patients diagnosed with HL (stage I-IV) between the years 2000 and 2012 using the National Cancer Data Base (n = 24,118). The National Cancer Data Base is a nationwide oncology outcomes database for more than 1500 American College of Surgeons Commission on Cancer accredited cancer programs. The study focused on the proportion of patients who received radiation therapy. Results Between the years 2000 and 2012, use of radiation therapy declined among all stages of HL (stage I: 53% to 40%, P =.0002; stage II: 52% to 36%, P <.0001; stage III: 21% to 10%, P <.0001; stage IV: 17% to 9%; P =.0002). Conclusion There has been a significant decline in the use of radiation therapy from 2000 to 2012 among all stages of HL, perhaps because of the studies that showed an increase in late complications with use of radiation therapy.

AB - Background Hodgkin lymphoma (HL) has come a long way from being a disease with high mortality to being highly curable, which thereby exposes survivors to the potential for long-term toxicities. Our aim was to analyze the National Cancer Data Base for trends in radiation therapy use among all stages of HL from 2000 to 2012 and to see if increased recognition of these risks has decreased the use of radiation therapy. Patients and Methods This was a retrospective study of patients diagnosed with HL (stage I-IV) between the years 2000 and 2012 using the National Cancer Data Base (n = 24,118). The National Cancer Data Base is a nationwide oncology outcomes database for more than 1500 American College of Surgeons Commission on Cancer accredited cancer programs. The study focused on the proportion of patients who received radiation therapy. Results Between the years 2000 and 2012, use of radiation therapy declined among all stages of HL (stage I: 53% to 40%, P =.0002; stage II: 52% to 36%, P <.0001; stage III: 21% to 10%, P <.0001; stage IV: 17% to 9%; P =.0002). Conclusion There has been a significant decline in the use of radiation therapy from 2000 to 2012 among all stages of HL, perhaps because of the studies that showed an increase in late complications with use of radiation therapy.

KW - Adult

KW - Cardiotoxicity

KW - Complications

KW - Radiotherapy

KW - Survivors

UR - http://www.scopus.com/inward/record.url?scp=84952876261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952876261&partnerID=8YFLogxK

U2 - 10.1016/j.clml.2015.11.006

DO - 10.1016/j.clml.2015.11.006

M3 - Article

C2 - 26702473

AN - SCOPUS:84952876261

VL - 16

SP - 12

EP - 17

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

SN - 2152-2669

IS - 1

ER -